Cholangitis sclerosing+4
RecruitingStudy on Low-Dose Aldesleukin for Patients with Pemphigus, Mucous Membrane Pemphigoid, Polymyositis, Dermatomyositis, and Primary Sclerosing Cholangitis
Study on Low-Dose Aldesleukin for Patients with Pemphigus, Mucous Membrane Pemphigoid, Polymyositis, Dermatomyositis, and Primary Sclerosing Cholangitis
- Disease:Cholangitis sclerosingDermatomyositis+3
- Substances:AldesleukinGlucose
Germany- Participants:18–64 years · 65+ years
- Substances:Aldesleukin
- Sponsor:Universitaetsklinikum Schleswig-Holstein AöR







